Overview

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Status:
Completed
Trial end date:
2016-03-17
Target enrollment:
Participant gender:
Summary
The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.
Phase:
N/A
Details
Lead Sponsor:
Bayer
Collaborator:
Novartis
Treatments:
Ciprofloxacin